Gastrobody Therapeutics’ cover photo
Gastrobody Therapeutics

Gastrobody Therapeutics

Biotechnology Research

Creating ultra-stable orally-administered protein therapeutics for treatment of GI tract diseases

About us

Gastrobody Therapeutics is a biopharmaceutical company creating ultrastable, orally-administered protein therapeutics to treat conditions of the gastrointestinal (GI) tract. Gastrobodies have the potential to be transformative against GI tract diseases by leveraging their specificity to the target and their unique ability to survive the harsh conditions within the GI tract.

Industry
Biotechnology Research
Company size
2-10 employees
Type
Privately Held

Employees at Gastrobody Therapeutics

Similar pages